EP4698183A1 - Pharmazeutische zusammensetzungen von vareniclin und verfahren dafür - Google Patents

Pharmazeutische zusammensetzungen von vareniclin und verfahren dafür

Info

Publication number
EP4698183A1
EP4698183A1 EP24792297.4A EP24792297A EP4698183A1 EP 4698183 A1 EP4698183 A1 EP 4698183A1 EP 24792297 A EP24792297 A EP 24792297A EP 4698183 A1 EP4698183 A1 EP 4698183A1
Authority
EP
European Patent Office
Prior art keywords
varenicline
pharmaceutical composition
pharmaceutically acceptable
composition according
nitrosamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24792297.4A
Other languages
English (en)
French (fr)
Inventor
Sathurappan Balaji
Venkat Iyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instapill Private Ltd
Original Assignee
Instapill Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instapill Private Ltd filed Critical Instapill Private Ltd
Publication of EP4698183A1 publication Critical patent/EP4698183A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP24792297.4A 2023-04-20 2024-04-20 Pharmazeutische zusammensetzungen von vareniclin und verfahren dafür Pending EP4698183A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202341028741 2023-04-20
PCT/IN2024/050417 WO2024218799A1 (en) 2023-04-20 2024-04-20 Pharmaceutical compositions of varenicline and process thereof

Publications (1)

Publication Number Publication Date
EP4698183A1 true EP4698183A1 (de) 2026-02-25

Family

ID=93152218

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24792297.4A Pending EP4698183A1 (de) 2023-04-20 2024-04-20 Pharmazeutische zusammensetzungen von vareniclin und verfahren dafür

Country Status (2)

Country Link
EP (1) EP4698183A1 (de)
WO (1) WO2024218799A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019501207A (ja) * 2016-01-08 2019-01-17 シーティーシー バイオ,インコーポレイテッド バレニクリンまたはこの薬学的に許容可能な塩を含有する、味の遮蔽された口腔投与用薬学製剤
IN456375B (de) * 2019-09-26 2023-10-03
CN115707470A (zh) * 2021-08-20 2023-02-21 山东威智中科药业有限公司 一种低亚硝胺杂质含量的伐尼克兰药物组合物及其制备方法与应用
WO2023012376A2 (en) * 2021-11-05 2023-02-09 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Prevention of the conversion of pharmaceutical agents into toxic n-nitrosamine compounds

Also Published As

Publication number Publication date
WO2024218799A1 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
EP2493457B1 (de) Schnell lösliche feste dosierungsform
RU2648760C2 (ru) Фармацевтическая композиция, содержащая оксигидроксид железа, способ ее получения и применение
JP7444967B2 (ja) 4-アミノ-3-置換ブタン酸誘導体の安定化製剤
WO2018122867A1 (en) Thin film formulations of 4-diphenylmethyl-1-piperazine derivatives and their salts
EP2563340A2 (de) Wasserlösliche pharmazeutische zusammensetzung
US12064414B2 (en) Stable amorphous Eliglustat premix and process for the preparation thereof
US20160287583A1 (en) Oral dispersible composition of a dpp-iv inhibitor
EP4183390A1 (de) Pharmazeutische schmelztablettendosierungsform von edoxaban
WO2024218799A1 (en) Pharmaceutical compositions of varenicline and process thereof
US20090269393A1 (en) Chewable Bilayer Tablet Formulation
EP3854385A1 (de) Darreichungsform von methotrexat
EP2098225B1 (de) Geschmacksunterdrückungssystem für nicht weichgemachte Arzneimittel
CA3138131A1 (en) Mini softgel naproxen composition
KR100435514B1 (ko) 실데나필 젖산염의 속효제형
EP4035654A1 (de) Schmelzbare pharmazeutische feste dosierungsform von rasagilin
AU2012241189A1 (en) Fast Dissolving Solid Dosage Form
CN114886860A (zh) 一种乙酰半胱氨酸药物组合物及其制剂和制备工艺
JP2011037840A (ja) 口腔内崩壊錠及びその製造方法
WO2017153822A1 (en) Resinates of pharamceutically acceptable salts of tofacitinib such as tofacitinib citrate, for taste masking
US20080031944A1 (en) Stabilization of lorazepam
WO2025253253A1 (en) Orodispersible solid composition in the form of film for oral administration of thyroid hormones
Rai et al. A REVIEW ON: ORAL DISPERSIBLE TABLETS
EP4525824A1 (de) Pharmazeutische zusammensetzung zur sublingualen verabreichung von clonidin
US20240307360A1 (en) Oral dispersible film of mitragynine
Kumar et al. FORMULATION AND IN-VITRO EVALUATION OF FAST DISSOLVING TABLETS OF CANDESARTAN CILEXETIL

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR